Elevated second trimester maternal serum β-HCG concentrations and subsequent adverse pregnancy outcome

1992 ◽  
Vol 44 (4) ◽  
pp. 485-486 ◽  
Author(s):  
Claudia P. Gravett ◽  
John G. Buckmaster ◽  
Peter T. Watson ◽  
Michael G. Gravett
Keyword(s):  
Pregnancy Outcome ◽  
Adverse Pregnancy Outcome ◽  
Maternal Serum ◽  
Second Trimester ◽  
Adverse Pregnancy ◽  
Β Hcg

The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum α-fetoprotein levels

1994 ◽  
Vol 171 (2) ◽  
pp. 315-320 ◽  
Author(s):  
James T. Christmas ◽  
Lauren V. Vanner ◽  
Robert M. Daniels ◽  
Joanne N. Bodurtha ◽  
Patricia M. Hays ◽  
...  
Keyword(s):  
Pregnancy Outcome ◽  
Adverse Pregnancy Outcome ◽  
Maternal Serum ◽  
Second Trimester ◽  
Adverse Pregnancy

Second trimester maternal serum marker and adverse pregnancy outcome

2011 ◽  
Vol 54 (11) ◽  
pp. 651 ◽  
Author(s):  
Se-Eun Cho ◽  
Yoo Jeong Shin ◽  
Hyo Jeong Kim ◽  
Hyun-Young Ji ◽  
Hye-Min Kwak ◽  
...  
Keyword(s):  
Pregnancy Outcome ◽  
Adverse Pregnancy Outcome ◽  
Serum Marker ◽  
Maternal Serum ◽  
Second Trimester ◽  
Adverse Pregnancy

Second-Trimester Maternal Serum Alpha-Fetoprotein and Risk of Adverse Pregnancy Outcome

2001 ◽  
Vol 97 (2) ◽  
pp. 277-282 ◽  
Author(s):  
TYRA G. KRAUSE ◽  
PETER CHRISTENS ◽  
JAN WOHLFAHRT ◽  
ULRIKKE LEI ◽  
TINE WESTERGAARD ◽  
...  
Keyword(s):  
Pregnancy Outcome ◽  
Adverse Pregnancy Outcome ◽  
Maternal Serum ◽  
Alpha Fetoprotein ◽  
Second Trimester ◽  
Serum Alpha Fetoprotein ◽  
Adverse Pregnancy

scholarly journals Evaluation of the variations and potential clinical use of second trimester serum markers for the detection of pre-eclampsia

2018 ◽  
Vol 7 (7) ◽  
pp. 2904
Author(s):  
Savita S. Gautam ◽  
Manmeet Kaur ◽  
Naimaa K. Chaudhary ◽  
Asha Sharma
Keyword(s):  
Adverse Pregnancy Outcome ◽  
Serum Marker ◽  
Serum Markers ◽  
Maternal Serum ◽  
Clinical Use ◽  
Second Trimester ◽  
Chi Square ◽  
Adverse Pregnancy ◽  
Β Hcg ◽  
In Pregnancy

Background: In many areas of world, hypertensive disease in pregnancy is the single most common cause of maternal death. Pregnancy associated hypertension remains unsolved despite decades of intensive research and remains the most significant problem in obstetrics. The aim of present study is to evaluate the variations and potential clinical use of second trimester serum markers for the detection of pre-eclampsia.Methods: In an observational study, estimations of serum of human chorionic gonadotropin (β-hCG) were done in 347 randomly selected women at 13-20 weeks of gestation in august 2015 to may 2016. Multiple of median (MOM) was calculated from charts of norms available for that weeks of pregnancy. The subjects were followed up till delivery for the development of hypertension in pregnancy and results analysed statistically with Chi-square test.Results: Out of 347, 47 women developed hypertyension and 2MOM of β hCG was significantly (P<0.001) elevated in those who developed hypertension compared to normotensive women. In our study group a significant associations between elevations in second trimester β-hCG and development of hypertension was observed. Thus with second trimester serum marker study, prediction of pre- eclampsia is possible at incipient stage and adverse pregnancy outcome can be minimized.Conclusions: Maternal serum β-hCG level was found to be significantly higher in hypertensive group than normal group.

Second-trimester maternal serum alpha-fetoprotein (MSAFP) iselevated in women with adverse pregnancy outcome associated with inherited thrombophilias

2001 ◽  
Vol 21 (8) ◽  
pp. 658-661 ◽  
Author(s):  
Yifat Ochshorn ◽  
Michael J. Kupferminc ◽  
Amiram Eldor ◽  
Igal Wolman ◽  
Joseph B. Lessing ◽  
...  
Keyword(s):  
Pregnancy Outcome ◽  
Adverse Pregnancy Outcome ◽  
Maternal Serum ◽  
Alpha Fetoprotein ◽  
Second Trimester ◽  
Serum Alpha Fetoprotein ◽  
Adverse Pregnancy
Sign in / Sign up

Export Citation Format

Share Document